Ani Pharmaceuticals (ANIP) Change in Taxes (2014 - 2026)

Ani Pharmaceuticals (ANIP) has 13 years of Change in Taxes data on file, last reported at $14.1 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Taxes rose 89.37% year-over-year to $14.1 million; the trailing twelve-month figure through Mar 2026 stood at -$8.9 million (down 418.84% YoY), and the FY2025 full-year result was -$15.5 million, down 997.6% from the prior year.
• Change in Taxes grew to $14.1 million in Q1 2026, from $472000.0 in the prior quarter.
• In the past five years, Change in Taxes ranged from a high of $14.1 million in Q1 2026 to a low of -$14.3 million in Q2 2024.
• A 5-year average of $527764.7 and a median of $92000.0 in 2023 frame the typical range for Change in Taxes.
• Across the five-year window, Change in Taxes surged 15538.78% in 2023 and plunged 3942.21% in 2024, its largest moves.
• Tracing ANIP's Change in Taxes over 5 years: stood at -$49000.0 in 2022, then surged by 15538.78% to $7.6 million in 2023, then soared by 69.9% to $12.9 million in 2024, then tumbled by 96.33% to $472000.0 in 2025, then jumped by 2884.53% to $14.1 million in 2026.
• Business Quant data shows ANIP's Change in Taxes at $14.1 million in Q1 2026, $472000.0 in Q4 2025, and -$12.5 million in Q3 2025.